Cargando…

P607: INTEGRATING MULTI-OMICS TO REVEAL THE CLONAL EVOLUTIONARY CHARACTERISTICS IN CLL PATIENTS WITH ZANUBRUTINIB RESISTANCE

Detalles Bibliográficos
Autores principales:	Zhu, Huayuan, Sha, Yeqin, Miao, Yi, Qin, Shuchao, Dai, Luomengjia, Qiu, Tonglu, Wu, Wei, Xia, Yi, Fan, Lei, Xu, Wei, LI, Jianyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429097/ http://dx.doi.org/10.1097/01.HS9.0000969332.27729.f0

Ejemplares similares

P592: SINGLE-CELL RNA SEQUENCING REVEALS THE SPATIAL HETEROGENEITY OF EXHAUSTED T CELLS IN BTKI-RESISTANT RICHTER TRANSFORMATION PATIENTS
por: Sha, Yeqin, et al.
Publicado: (2023)

Ibrutinib plus fludarabine, cyclophosphamide and rituximab (iFCR) as initial treatment in chronic lymphocytic leukemia/ small lymphocytic leukemia with or without TP53 aberrations: a prospective real-world study in Chinese cohort
por: Miao, Yi, et al.
Publicado: (2023)

Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing
por: Dai, Luomengjia, et al.
Publicado: (2023)

The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia
por: Sha, Yeqin, et al.
Publicado: (2022)

Advancements in the Treatment of CLL: The Rise of Zanubrutinib as a Preferred Therapeutic Option
por: Molica, Stefano, et al.
Publicado: (2023)

Spectrum and trigger identification of hemophagocytic lymphohistiocytosis in adults: A single-center analysis of 555 cases
por: Miao, Yi, et al.
Publicado: (2022)

Evaluation of uterine scar healing by transvaginal ultrasound in 607 nonpregnant women with a history of cesarean section
por: Zhou, Xingchen, et al.
Publicado: (2021)

Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
por: Blombery, Piers, et al.
Publicado: (2022)

Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series
por: Zhang, Yan, et al.
Publicado: (2021)

Clonal expansion in B-CLL: Fungal drivers or self-service?
por: Greaves, Mel
Publicado: (2013)

Memorandum: extension R607
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1979)

Drift chamber for R607
por: CERN PhotoLab
Publicado: (1977)

R607 Drift Chamber
Publicado: (1977)

R607 drift chamber
Publicado: (1977)

Zanubrutinib: past, present, and future
por: Tam, Constantine S., et al.
Publicado: (2023)

Transformation of CLL to ALCL: the role of clonality studies in diagnostic molecular haematopathology
por: Colling, Richard, et al.
Publicado: (2016)

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies
por: Tam, Constantine S., et al.
Publicado: (2022)

Memorandum: Collaboration of experiment R 607
por: Sens, Johannes C
Publicado: (1978)

Status report on experiment R607
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1978)

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA AND SMALL LYMPHOCYTIC LYMPHOMA (R/R CLL/SLL): IMPACT ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)
por: Eichhorst, Barbara, et al.
Publicado: (2023)

Simultaneous development of zanubrutinib in the USA and China
por: Li, Guanqiao, et al.
Publicado: (2020)

Correction: Zanubrutinib: past, present, and future
por: Tam, Constantine S., et al.
Publicado: (2023)

Clonal hematopoiesis, multi-omics and coronary artery disease
por: Nakao, Tetsushi, et al.
Publicado: (2022)

P1603: EFFICACY AND SAFETY OF BRUTON’S TYROSINE KINASE INHIBITOR ZANUBRUTINIB IN ITP
por: Huang, Qiu-Sha, et al.
Publicado: (2023)

P639: ZANUBRUTINIB (ZANU) VS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EXTENDED FOLLOW-UP OF THE SEQUOIA STUDY
por: Munir, Talha, et al.
Publicado: (2023)

Clonality and Evolutionary History of Rhabdomyosarcoma
por: Chen, Li, et al.
Publicado: (2015)

Memorandum: charm search in exp-R607
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1979)

R607 at intersection I6, ISR
por: CERN PhotoLab
Publicado: (1979)

A novel UHPLC‒MS/MS method for quantitative analysis of zanubrutinib in rat plasma: application to an in vivo interaction study between zanubrutinib and triazole antifungal
por: Tang, Peng-fei, et al.
Publicado: (2023)

Efficacy of Zanubrutinib in the Treatment of Bing–Neel Syndrome
por: Wong, Jonathan, et al.
Publicado: (2018)

Zanubrutinib for mantle cell lymphoma, Waldenström’s macroglobulinaemia
Publicado: (2021)

Zanubrutinib in lymphoproliferative disorders: a comprehensive review
por: Muñoz, Javier, et al.
Publicado: (2022)

eGPS 1.0: comprehensive software for multi-omic and evolutionary analyses
por: Yu, Dalang, et al.
Publicado: (2019)

A proposed mechanism for IS607-family serine transposases
por: Boocock, Martin R, et al.
Publicado: (2013)

Not all lymphoid aggregates in chronic lymphocytic leukemia (CLL) patients are due to CLL!
por: Mahapatra, Lily, et al.
Publicado: (2021)

Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First
por: Deshpande, Anagha, et al.
Publicado: (2022)

Disseminated fungal infection in a patient receiving zanubrutinib
por: Walsh, Madalyn, et al.
Publicado: (2023)

Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia
por: Tam, Constantine S., et al.
Publicado: (2023)

OmicsSuite: a customized and pipelined suite for analysis and visualization of multi-omics big data
por: Miao, Ben-Ben, et al.
Publicado: (2023)

NGS Analysis of Clonality and Minimal Residual Disease in a Patient with Concurrent Richter's Transformation and CLL/SLL
por: Kadkol, Shrihari S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2rievsicq8400qp6j2gd9ert7u